CA
ABBV icon

Clearstead Advisors’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$19M Buy
102,462
+2,779
+3% +$516K 0.27% 86
2025
Q1
$20.9M Sell
99,683
-390
-0.4% -$81.7K 0.32% 71
2024
Q4
$17.8M Sell
100,073
-384
-0.4% -$68.2K 0.27% 87
2024
Q3
$19.8M Buy
100,457
+2,001
+2% +$395K 0.31% 75
2024
Q2
$16.9M Buy
98,456
+44,861
+84% +$7.69M 0.29% 77
2024
Q1
$8.64M Sell
53,595
-636
-1% -$103K 0.43% 48
2023
Q4
$8.4M Sell
54,231
-68,078
-56% -$10.6M 0.45% 43
2023
Q3
$18.2M Buy
122,309
+69,699
+132% +$10.4M 0.53% 44
2023
Q2
$7.09M Buy
52,610
+6,017
+13% +$811K 0.43% 48
2023
Q1
$7.43M Buy
46,593
+911
+2% +$145K 0.54% 38
2022
Q4
$7.38M Sell
45,682
-2,013
-4% -$325K 0.58% 37
2022
Q3
$6.4M Sell
47,695
-13,655
-22% -$1.83M 0.59% 35
2022
Q2
$9.4M Buy
61,350
+422
+0.7% +$64.6K 0.73% 31
2022
Q1
$9.88M Buy
60,928
+746
+1% +$121K 0.67% 29
2021
Q4
$8.15M Buy
60,182
+2,451
+4% +$332K 0.55% 36
2021
Q3
$6.23M Buy
57,731
+3,469
+6% +$374K 0.46% 46
2021
Q2
$6.11M Buy
54,262
+577
+1% +$65K 0.47% 46
2021
Q1
$5.81M Buy
53,685
+5,517
+11% +$597K 0.48% 44
2020
Q4
$5.16M Buy
48,168
+9,890
+26% +$1.06M 0.47% 46
2020
Q3
$3.35M Buy
38,278
+771
+2% +$67.5K 0.36% 62
2020
Q2
$3.68M Buy
37,507
+10,834
+41% +$1.06M 0.43% 54
2020
Q1
$2.03M Sell
26,673
-2,097
-7% -$160K 0.3% 67
2019
Q4
$2.55M Sell
28,770
-180
-0.6% -$15.9K 0.31% 70
2019
Q3
$2.19M Sell
28,950
-3,009
-9% -$228K 0.29% 71
2019
Q2
$2.32M Buy
31,959
+577
+2% +$42K 0.31% 66
2019
Q1
$2.53M Sell
31,382
-4,703
-13% -$379K 0.35% 63
2018
Q4
$3.33M Sell
36,085
-909
-2% -$83.8K 0.52% 51
2018
Q3
$3.5M Buy
36,994
+425
+1% +$40.2K 0.48% 48
2018
Q2
$3.39M Buy
36,569
+1,321
+4% +$122K 0.48% 46
2018
Q1
$3.34M Sell
35,248
-1,575
-4% -$149K 0.48% 46
2017
Q4
$3.56M Sell
36,823
-4,113
-10% -$398K 0.48% 47
2017
Q3
$3.64M Sell
40,936
-302
-0.7% -$26.8K 0.47% 51
2017
Q2
$2.99M Buy
41,238
+5,092
+14% +$369K 0.44% 53
2017
Q1
$2.36M Buy
36,146
+3,268
+10% +$213K 0.34% 59
2016
Q4
$2.06M Buy
+32,878
New +$2.06M 0.33% 55